Obesity drug developer Orexigen in bankruptcy to pursue sale - Reute...

03/13/18


Obesity drug developer Orexigen in bankruptcy to pursue sale
Reuters
Obesity treatment developer Orexigen Therapeutics Inc filed for Chapter 11 bankruptcy protection on Monday to sell itself after efforts last year to strengthen its balance sheet came up short and left the company low on cash. Orexigen President and ...

[more]